METHOD FOR SURGICAL TREATMENT OF RECURRENT RETINAL DETACHMENT Russian patent published in 2022 - IPC A61F9/07 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology. A microinvasive access to the vitreous cavity is carried out against the background of silicone oil (SO) tamponade. SO is removed by active aspiration, fluid is irrigated, epiretinal membranes and remnants of the vitreous body are contrasted. Remains of the vitreous body, epiretinal and subretinal membranes are removed by performing a dosed retinotomy. Endolaser coagulation of the retina is performed, a perfluoroorganic compound (PFOC) is administered, and tamponade of the vitreal cavity of the SM is repeated. PFOC is injected into the central zone of the retina up to the vascular arcades, then the location of the subretinal strands is visually assessed, and if the strands occupy 1-2 sectors of the retina, then a partial retinotomy is performed using a vitreotomy. If more than 2 sectors - circular retinotomy; PFOC is left in the vitreous cavity, the fluid is replaced with air. Then, in the air environment, the retinal flap is turned away in the area of retinotomy in the zone of subretinal cords, the subretinal cords are bimanually removed, the air is replaced with liquid. PFOC is added to the edge of the retinotomy, after which endolaser coagulation is performed along the vessels and in the area of the retinotomy. Next, PFOC is removed and the air is replaced with SO, the operation is completed by removing the ports and applying transconjunctival interrupted sutures to the sites of their installation

EFFECT: method provides microinvasive and safe treatment of retinal detachment recurrence without damage to eye structures, which improves visual functions and restores binocular vision.

1 cl, 3 ex